NMD4C, Muscular Dystrophy Canada (MDC), and Jesse’s Journey (JJ) are pleased to invite you to a webinar on the current state of Duchenne muscular dystrophy (DMD) in Canada.

This webinar is primarily targeted at Canadian clinicians and clinical academics with an interest in DMD. The speakers will discuss current DMD issues both generally and in the context of COVID-19. It will be similar to previous summits, but in a short webinar format. MDC, NMD4C, and JJ are providing organisational and technical support, and this is an independent clinical/academic webinar with no industry participation or sponsorship.

Register HERE

Topics and speakers:

COVID-19 update: Lockdown, going back to work and school, and steroid therapy

Dr. Laura McAdam

Exon skipping update for Canada

Dr. Craig Campbell (NMD4C Investigator)

Small molecule update for Canada

Dr. Kathryn Selby (NMD4C Investigator)

Gene therapy update for Canada

Dr. James Dowling (NMD4C Steering Committee member)

Research perspective: CRISPR for DMD

Dr. Ronald Cohn

If you have any questions, please email